H
Harvest
Tax-loss replacement research
NBIX
Neurocrine Biosciences
Health Care›Biotechnology›Biotechnology
28 stocks · 12 ETFs
data as of Oct 12, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for NBIX

Among the 28 Biotechnology peers screened, EXEL (Exelixis) has tracked NBIX most closely over the past year, with a return correlation of 0.46. The strongest fund stand-in is IBB (iShares Biotechnology ETF) at 0.49 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
EXELExelixisBiotechnology0.460.300.330.38
INCYIncyteBiotechnology0.370.320.360.39
PTGXProtagonist Therapeutics, Inc.Biotechnology0.350.170.180.12
TGTXTG Therapeutics, Inc.Biotechnology0.340.200.210.23
BMRNBioMarin PharmaceuticalBiotechnology0.320.280.310.36
XNCRXencor IncBiotechnology0.310.260.270.32
VIRVir Biotechnology, Inc.Biotechnology0.290.230.210.11
HALOHalozymeBiotechnology0.290.250.260.32
ARWRArrowhead PharmaceuticalsBiotechnology0.290.240.290.29
VRTXVertex PharmaceuticalsBiotechnology0.290.210.250.34
KRYSKrystal BiotechBiotechnology0.290.230.180.21
BIIBBiogen Inc.Biotechnology0.290.250.250.26
SRPTSarepta TherapeuticsBiotechnology0.280.170.210.26
RCUSArcus Biosciences, Inc.Biotechnology0.280.250.250.24
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.280.170.230.19
AMGNAmgen Inc.Biotechnology0.270.250.220.29
CYTKCytokineticsBiotechnology0.250.200.240.25
FTREFortreaBiotechnology0.250.240.23—
GILDGilead SciencesBiotechnology0.240.200.210.23
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.240.220.250.30
ROIVRoivant SciencesBiotechnology0.240.250.18—
REGNRegeneron PharmaceuticalsBiotechnology0.220.250.270.31
VCELVericelBiotechnology0.210.240.260.24
ALNYAlnylam PharmaceuticalsBiotechnology0.200.250.270.35
UTHRUnited TherapeuticsBiotechnology0.160.210.220.27
RGENRepligenBiotechnology0.150.230.240.28
MRNAModerna Inc.Biotechnology0.130.110.120.11
ADMAADMA Biologics, Inc.Biotechnology0.120.180.210.17
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.490.450.460.52
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.480.440.450.52
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.370.380.390.44
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.350.370.380.43
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.350.370.380.43
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.330.330.340.41
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.320.350.360.41
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.310.310.340.39
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.290.320.330.39
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.270.280.290.36
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.260.210.260.32
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.180.290.310.36
NEXT STEPS

Harvesting a loss in NBIX?

RELATED

Replacement research for NBIX's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.